National Milk Producers Federation

NMPF Comments on Proposed Approval Process for Genetically Engineered Animals - November 18, 2008

In response to USDA's Animal Plant Health Inspection Service (APHIS) Request for Information on Genetically Engineered Animals, NMPF submitted a letter that expressed support for a comprehensive mandatory pre-market approval process for GE animals regardless of their intended use. The letter reiterated the joint comments that NMPF and the U.S. Dairy Export Council (USDEC) sent to the Food and Drug Administration (FDA) on the same day regarding FDA's "Guidance for Industry: Regulation of Genetically Engineered Animals Containing Heritable rDNA."

NMPF Supports USDA Request to Maintain Moratorium on Cloned Animal Products During Period of Additional Review - January 15, 2008

As had been widely reported, the Food and Drug Administration completed its risk assessment on cloned animal products, and released that report on January 15th. On the same day, NMPF issued a response to FDA's announcement and to the USDA's appeal to keep the voluntary moratorium on cloned animal products in place. To see the complete press release, click here.

For further information on the risk assessment and next steps, visit the FDA and USDA websites. A fact sheet with more details on cloning is available here.

NMPF Statement Regarding the Creation of a Supply Chain Management System to Monitor Cloned Livestock - December 19, 2007

A statement was issued Dec. 19, 2007, by the National Milk Producers Federation, in response to the announcement by companies involved in cloning livestock that they have worked with the food marketing chain to develop a supply management chain system to track cattle and swine clones. For the full statement, click here.

See also: The Washington Post's Dec. 19, 2007 article about clone product labeling.

Comments to USDA - May 3, 2007

On May 3, 2007, NMPF submitted comments to USDA on our cloning position. NMPF has carefully reviewed the documents FDA has requested comment on and will provide comments in the following areas: (1) the Draft Animal Cloning Risk Assessment (Risk Assessment); (2) the Draft Risk Management Plan (Risk Management Plan); (3) Labeling Guidance for Industry (Guidance for Industry); (4) interagency consultation; and (5) market impacts. The full comments are available in this document.